Regis Custom Pharma is a US-based contract development and manufacturing organisation (CDMO) that specializes in the development and manufacture of New Chemical Entities (NCEs). Offering a comprehensive range of custom pharmaceutical development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs), Regis Custom Pharma supports the journey of lead molecules from preclinical to clinical phases. The company has built a successful history over the past 65 years, assisting in the development of numerous new drug candidates through services that include process optimization, process registration, and validation. Additionally, Regis provides a selection of innovative chromatography products and high-purity reagents distributed globally.

Services include:
- Analytical Services
- cGMP Synthesis
- Chiral Separations
- R&D
- Contract Development and Manufacturing (CDMO)
- Forced Degradation Studies
- Manufacturing
- APIs (Active Pharmaceutical Ingredients)
- High Potency
- Micronization
- Particle Characterization
- Process Development
- Project Management
- Quality QA/QC
- Scale-Up
- Stability
- ICH
- Validation
- Clinical
- Regulatory Services
- Containment

Regis Custom Pharma remains committed to delivering high-quality services and products tailored to meet the needs of the pharmaceutical industry. For more information, please visit registech.com.